Skip to content


Reyataz (atazanavir) is a small molecule pharmaceutical. Atazanavir was first approved as Reyataz on 2003-06-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
Trade Name Reyataz
Common Name Atazanavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type)
Get full access now